OCEAN Trial: Ablate Afib. Assess. Anticoagulate? 🌊 episode artwork

EPISODE · Nov 12, 2025 · 3 MIN

OCEAN Trial: Ablate Afib. Assess. Anticoagulate? 🌊

from Dr RR Baliga's "Got Knowledge Doc" Podkast · host MasterMedFacts LLC

🌊 OCEAN Trial offers fresh insight into antithrombotic therapy after successful AF ablation. In 1284 patients followed for 3 years, event rates were remarkably low 🌟. Rivaroxaban did not show superiority over aspirin for preventing stroke, systemic embolism, or covert embolic events, while bleeding risk was higher with anticoagulation.   🧠 96% had no new infarcts on MRI at follow-up.   Published in NEJM (2025) — a valuable contribution to nuanced AF post-ablation care.

Episode metadata supplied by the publisher feed · Published Nov 12, 2025

NOW PLAYING

OCEAN Trial: Ablate Afib. Assess. Anticoagulate? 🌊

0:00 3:53

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of Dr RR Baliga's "Got Knowledge Doc" Podkast?

This episode is 3 minutes long.

When was this Dr RR Baliga's "Got Knowledge Doc" Podkast episode published?

This episode was published on November 12, 2025.

What is this episode about?

🌊 OCEAN Trial offers fresh insight into antithrombotic therapy after successful AF ablation. In 1284 patients followed for 3 years, event rates were remarkably low 🌟. Rivaroxaban did not show superiority over aspirin for preventing stroke,...

Can I download this Dr RR Baliga's "Got Knowledge Doc" Podkast episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!